Effect of Shuanghu Qinggan Granule (双虎清肝颗粒) and Yigan Yiqi Jieyu Granule (乙肝益气解郁颗粒) plus lamivudine on chronic hepatitis B patients: A randomized double-blind placebo-controlled trial
Back to article page
OriginalPaper|Updated:2021-09-17
|
Effect of Shuanghu Qinggan Granule (双虎清肝颗粒) and Yigan Yiqi Jieyu Granule (乙肝益气解郁颗粒) plus lamivudine on chronic hepatitis B patients: A randomized double-blind placebo-controlled trial
Effect of Shuanghu Qinggan Granule (双虎清肝颗粒) and Yigan Yiqi Jieyu Granule (乙肝益气解郁颗粒) plus lamivudine on chronic hepatitis B patients: A randomized double-blind placebo-controlled trial
Yong-an Ye (, ), De-lu Tian (, 等. Effect of Shuanghu Qinggan Granule (双虎清肝颗粒) and Yigan Yiqi Jieyu Granule (乙肝益气解郁颗粒) plus lamivudine on chronic hepatitis B patients: A randomized double-blind placebo-controlled trial[J/OL]. 1-7.
Yong-an Ye
(, ), De-lu Tian
(, et al. Effect of Shuanghu Qinggan Granule (双虎清肝颗粒) and Yigan Yiqi Jieyu Granule (乙肝益气解郁颗粒) plus lamivudine on chronic hepatitis B patients: A randomized double-blind placebo-controlled trial[J/OL]. 1-7.
Yong-an Ye (, ), De-lu Tian (, 等. Effect of Shuanghu Qinggan Granule (双虎清肝颗粒) and Yigan Yiqi Jieyu Granule (乙肝益气解郁颗粒) plus lamivudine on chronic hepatitis B patients: A randomized double-blind placebo-controlled trial[J/OL]. 1-7. DOI: 10.1007/s11655-016-2519-9.
Yong-an Ye
(, ), De-lu Tian
(, et al. Effect of Shuanghu Qinggan Granule (双虎清肝颗粒) and Yigan Yiqi Jieyu Granule (乙肝益气解郁颗粒) plus lamivudine on chronic hepatitis B patients: A randomized double-blind placebo-controlled trial[J/OL]. 1-7. DOI: 10.1007/s11655-016-2519-9.
Effect of Shuanghu Qinggan Granule (双虎清肝颗粒) and Yigan Yiqi Jieyu Granule (乙肝益气解郁颗粒) plus lamivudine on chronic hepatitis B patients: A randomized double-blind placebo-controlled trial
Efficacy of Biejiajian Pill on Intestinal Microbiota in Patients with Hepatitis B Cirrhosis/Liver Fibrosis: A Randomized Double-Blind Controlled Trial
Reyanning Mixture on Asymptomatic or Mild SARS-CoV-2 Infection in Children and Adolescents: A Randomized Controlled Trial
相关作者
暂无数据
相关机构
Center of Liver Diseases Division 3, Beijing Ditan Hospital, Capital Medical University, Beijing, China;Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China;National Center for Infectious Diseases, Beijing, China;Peking University Ditan Teaching Hospital, Beijing, China;Central of Integrated Chinese and Western Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China;China Traditional Chinese Medicine Holdings Co. Limited, Guangzhou, China
Department of Emergency, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China;Acupuncture and Massage College, Shanghai University of Traditional Chinese Medicine, Shanghai, China;Department of Health Management, The First Affiliated Hospital of Nanchang University, Nanchang, China;Jiangxi Provincial Traditional Chinese Medicine Nephropathy Clinical Research Center, Jiujiang Hospital of Traditional Chinese Medicine, Jiujiang, Jiangxi Province, China;Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China;Institute of Critical Care, Shanghai University of Traditional Chinese Medicine, Shanghai, China